US Broker Ratings

Tempus AI, Inc. (TEM) Stock Analysis: A Balanced Look at Its 45% Potential Upside

Tempus AI, Inc. (NASDAQ: TEM), a prominent player in the healthcare technology sector, presents a compelling opportunity for investors seeking growth in the ever-evolving health information services industry. With a..

Krystal Biotech (KRYS) Investor Outlook: Robust Growth Prospects with 8.32% Potential Upside

Krystal Biotech, Inc. (NASDAQ: KRYS) is drawing significant attention in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $8.83 billion, this Pittsburgh-based company is at..

Elevance Health, Inc. (ELV) Stock Analysis: Exploring a Promising 1.5% Potential Upside in the Healthcare Sector

Elevance Health, Inc. (NYSE: ELV), a major player in the U.S. healthcare plans industry, is attracting attention with its substantial market cap of $85.71 billion and a current stock price..

Hologic, Inc. (HOLX) Stock Analysis: Navigating Steady Growth in the Healthcare Sector

Hologic, Inc. (NASDAQ: HOLX) stands as a key player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $16.97 billion, this Massachusetts-based..

Takeda Pharmaceutical (TAK) Stock Analysis: Exploring a Promising 25.97% Upside Potential

Takeda Pharmaceutical Company Limited (NYSE: TAK), a titan in the healthcare sector, stands as a compelling investment opportunity for those eyeing the drug manufacturing industry. With a market capitalization of..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating Growth Amidst Valuation Challenges

Integer Holdings Corporation (NYSE: ITGR) is a notable player in the healthcare sector, specializing in medical devices. With its headquarters in Plano, Texas, the company has established a significant presence..

HCA Healthcare, Inc. (HCA) Stock Analysis: A Potential 29.66% Upside Amid Strong Analyst Confidence

HCA Healthcare, Inc. (NYSE: HCA), a titan in the medical care facilities industry, commands attention with a market capitalization of $87.42 billion. Based in Nashville, Tennessee, this healthcare behemoth operates..

Biogen Inc. (BIIB) Stock Analysis: Navigating a Potential 13% Upside Amidst Robust Drug Pipeline

Biogen Inc. (NASDAQ: BIIB), a stalwart in the healthcare sector, stands as a significant player within the general drug manufacturing industry. With a current market capitalization of $28.61 billion, Biogen..

Atrium Therapeutics, Inc. (RNA) Stock Analysis: Exploring a 90.99% Potential Upside in RNA Therapeutics

Atrium Therapeutics, Inc. (NASDAQ: RNA) is capturing investor attention with a remarkable potential upside of 90.99%, according to recent analyst ratings. This San Diego-based biopharmaceutical company is pioneering the development..

Quest Diagnostics (DGX) Stock Analysis: Exploring a 14.46% Potential Upside in the Diagnostics Sector

Quest Diagnostics Incorporated (NYSE: DGX), a key player in the Healthcare sector, specifically within the Diagnostics & Research industry, is currently garnering significant attention from investors. With a market capitalization..

AptarGroup, Inc. (ATR) Stock Analysis: A 40% Upside Potential in the Healthcare Sector

AptarGroup, Inc. (NYSE: ATR) stands out as a compelling investment opportunity in the healthcare sector, particularly for investors eyeing growth potential. As a key player in the medical instruments and..

Legend Biotech Corporation (LEGN) Stock Analysis: Unveiling an 88.61% Potential Upside in Biotechnology

Legend Biotech Corporation (NASDAQ: LEGN), a promising player in the biotechnology sector, has captured investor attention with its innovative approach to combating cancer through novel cell therapies. Headquartered in Somerset,..

Telix Pharmaceuticals Limited (TLX): Investor Outlook on a Biotech Powerhouse with 123.80% Potential Upside

Telix Pharmaceuticals Limited (ASX: TLX), an Australian-based biopharmaceutical company, is drawing significant attention from investors, especially with a projected 123.80% potential upside. As a key player in the biotechnology industry,..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: Strong Buy Ratings and Promising Pipeline Propel Growth Potential

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, is swiftly capturing investor attention with its robust pipeline and consistent financial performance. Headquartered in Dublin, Ireland, Jazz..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: A 39% Upside Potential Amidst Strong Analyst Ratings

Prestige Consumer Healthcare Inc. (PBH) finds itself uniquely positioned within the healthcare sector, particularly in the niche of over-the-counter (OTC) drug manufacturing. A staple in households across North America and..

Amgen Inc. (AMGN) Stock Analysis: Strong ROE and Promising Outlook in the Healthcare Sector

Amgen Inc. (AMGN), a stalwart in the healthcare sector, continues to make waves with its robust financial performance and innovative therapeutic solutions. Headquartered in Thousand Oaks, California, Amgen is a..

Ascendis Pharma A/S (ASND) Stock Analysis: Riding the Wave of Impressive Revenue Growth and Analyst Optimism

Ascendis Pharma A/S (NASDAQ: ASND), a prominent player in the biotechnology industry, is capturing investor attention with its strong market positioning and impressive growth metrics. Based in Hellerup, Denmark, Ascendis..

Qiagen N.V. (QGEN) Stock Analysis: Evaluating the 24.59% Potential Upside

Qiagen N.V. (NYSE: QGEN), a prominent player in the healthcare sector specializing in diagnostics and research, has recently captured the attention of investors, not least due to its significant growth..

Glaukos Corporation (GKOS) Stock Analysis: Exploring a 28.5% Potential Upside with a Strong Buy Consensus

Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector specializing in medical devices, particularly ophthalmic pharmaceuticals, is capturing investor attention with its robust growth prospects and substantial potential..

TransMedics Group, Inc. (TMDX) Stock Analysis: Unveiling a 71% Potential Upside in the Medical Device Sector

For investors with an appetite for breakthrough medical technologies, TransMedics Group, Inc. (TMDX) presents a compelling opportunity in the healthcare sector. Based in Andover, Massachusetts, TransMedics is pioneering the transformation..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds